Medicine and science have made fantastic progress over the last hundred years. The advancements help people on a daily basis to combat illness and live longer. One of the diseases science is still trying to cure cancer. It is a tricky one because it is very unpredictable. At this point, there are success stories, and then there are those not so lucky. However, scientists and researchers don’t plan on giving up till they have achieved their goal – to cure the disease completely in all its various forms. One such researcher is Mikhail Blagosklonny whose name is not very well-known to many people.
With a background in oncology, Mikhail Blagosklonny primarily studies cancer and how it relates to age. Oder people are in the higher risk group even though there are different reasons people encounter this disease in life and not all of them are yet explained. However, there is an idea that a possibility of preventing cancer is more likely achievable than curing it. Advanced stages of the disease cannot be cured so people can only manage it and try to raise their quality of life as much as possible. Researchers also want to find a less invasive cancer therapy and read full article.
The current methods – chemotherapy and radiation have severed side-effects. People experience nausea, weakness and other unpleasant things after they spend time receiving treatment. Many are not able to attend therapy sessions alone since they are unable to get back home afterward. Creating a treatment method that would take away the side-effects or at least decrease their intensity would be a huge step towards the big goal. Mikhail Blagosklonny believes that aging happens because human cells get damaged over time, and at some point, they lose their ability to carry out repairs. However, using rapamycin and other rapalogs might extend human life, increasing the quality of life in the process.
Improving the immunity also helps and this is what a rapamycin alternative – Evirolimus achieves. Rapamycin itself is used mainly for patients after transplantations to ensure that their body will accept the new addition. It is also employed in cases people suffer from age-related illnesses. There is an idea that extending the human life would allow the cells to change and cancer cells would not be able to form or disguise themselves in the body. However, any treatment would have to be administered before the diagnosis of cancer since otherwise, it would not be effective and what Dr. Mikhail knows.
Mikhail Blagosklonny is passionate about this field is study. St. Petersburg was where his interest for oncology was born after studies and receiving his M.D. and later his Ph.D. in medicine. Mikhail chose cardiology as a field of specialization and has not left it since but acquired more knowledge and experience working in the States. He decided to dedicate his world and life to research and publication. One of the most well-known journals he works for is Oncotarget and Mikhail’s lacrosse camp.
Blagosklonny believes that offering scientists an opportunity to publish their research is a significant step towards the goal. It is a peer- reviewed journal and offers its readers the newest research as well as oncology-related news and http://healingmagic.net/2017/01/04/mikhail-blagosklonnys-plans-for-oncology/.
Eric Lefkofsky is the founder and CEO of the company Tempus. Tempus was an entity created that was created with the purpose of redefining how genomic data is used in clinical settings. The goal is to help benefit as many patients as possible by learning more about how genomic data that is collected can be used by providing physicians with more tools to help them treat patients more effectively.
Lefkofsky has overseen the company builds a massive, state-of-the-art facility called The Tempus Lab, which is a research and technology care clinic that helps do research to further what is known about genomics. The clinic currently samples and sequences the genomics of over 50,000 patients annually. The general sequencing procedure is complete in about two or three weeks after receiving the patient’s samples that are to be tested.
Tempus is also unique in that it works directly with the patient to help do their RNA and DNA sequencing. Tempus is always seeking to improve their capabilities to ensure they have the most cutting -edge procedures to ensure the accuracy of their genomic findings, and also strive to provide the patient with a complete picture of their genomic makeup. The ultimate result is that Tempus provides physicians with the tools to help make the most cutting-edge decision for each patient based on data-driven results and what Eric knows.
In addition to all of his excellent work as the CEO and founder of Tempus, that is not all that Eric Lefkofsky does to keep himself occupied. Lefkofsky’s accomplishments go well beyond just the Tempus agency. Lefkofsky has expanded his work into other areas, and he is also the founder and Chairman of the huge hit coupon site Groupon. In addition, Lefkofsky is also an adjunct professor at the University of Chicago and the author of “Accelerated Disruption: Understanding the True Speed of Innovation” and more information click here.
Other Reference: http://lefkofskyfoundation.com/
Eric Lefkofsky is the co-founder of Tempus. Tempus is a startup that is fighting against cancer. The aim of Tempus is to provide data that can help doctors at the University of Chicago find more effective ways to treat breast cancer and their patients who suffer from it. Through a partnership with the University of Chicago Medicine, the hope is that a treatment plan for every patient can be personalized and therefore better able to treat the patient.
The technology used by Tempus can provide doctors with the knowledge to create treatments immediately for their patients. Tempus hopes to expand their partnerships so that more patients can receive better treatment and hopefully achieve better outcomes and Eric’s lacrosse camp.
Eric Lefkofsky co-founded Tempus with the goal of fighting cancer. His triumphs do not end there. His road to the creation of his many companies was made possible after graduating from the University of Michigan and eventually the University ofMichihagn Law School where he received his Juris Doctor. He has created many companies during his career. Some of the companies he had a hand at establishing include Groupon, Mediaocean and Echo Global Logistics. His career is very expansive and his companies range in fields from e-commerce to media. Eric Lefkofsky is involved in many different areas of business and beyond.
Eric Lefkofsky has a desire to help which is clear by his creation of Tempus as well as other aspects of his life. A huge portion of Eric Lefkofsky’s life is devoted to his charitable organizations. The Lefkofsky Family Foundation is an organization that is finds and provides solutions to positively impact communities in need. He also is involved in many boards and organizations such as The Art Institute of Chicago, The Museum of Science and Industry, Trustee of Lurie Children’s Hospital of Chicago, and World Business Chicago.
Eric Lefkofsky is a very successful man who has not only created a company with the aim of defeating cancer, but many other companies that have allowed him to give back to the community. Eric Lefkofsky has used his career to create a positive change in not only communities but the world.